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EPIDEMIOLOGICAL STUDIES EXPLORING the connection between hypertension and cancer incidence found a higher cancer mortality in hypertensive patients (9) and an increased risk to develop kidney cancer (6, 19) . In most patients with hypertension, the activity of renin is either inappropriately normal (in relation to sodium balance) or even elevated (14) . Elevated levels are a typical feature of patients with renoparenchymal, especially renal vascular, hypertension. In particular, the renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension supports the role of a stimulated renin-angiotensin system (RAS) (12) . ANG II is one of the oldest known peptide hormones. It is generated from the precursor protein angiotensinogen, predominantly by the actions of renin and angiotensin-converting enzyme. ANG II, the main effector of the RAS, is a major regulator of blood pressure and cardiovascular homeostasis and can cause hypertension and kidney diseases. Beside the systemic RAS, which produces the plasma ANG II, a functional local RAS, and accordingly a local ANG II production, has been found in various organs, for example in the kidney, heart, and brain (2, 17) .
The actions of ANG II are mediated by two receptor molecules, the ANG II type 1 receptor (AT 1 ) and the ANG II type 2 receptor (AT 2 ). AT 1 receptors are expressed in many tissues, whereas AT 2 receptors are highest in fetal tissues (25) . All classic physiological effects of ANG II, such as vasoconstriction, aldosterone and vasopressin release, sodium and water retention, are mediated by the AT 1 receptor. Via this receptor, ANG II is also involved in cell proliferation, nephrosclerosis, endothelial dysfunction, and processes leading to atherothrombosis. The AT 2 receptor often functions as a counterregulatory receptor and is involved, for example, in cell differentiation and apoptosis (4, 13) .
In proximal tubule cells, activation of the AT 1 receptor by ANG II led to the induction of NAD(P)H-oxidase, a multienzyme complex which enhances intracellular synthesis of reactive oxygen species (ROS) (10) . Increased formation of ROS, of various etiology, is associated with the induction of genomic damage (11) .
The present study was undertaken to characterize the genotoxic effects of ANG II in vitro in the epithelial porcine kidney cell line LLC-PK 1 . We hypothesize these effects to be mediated by the AT 1 receptor, which upon activation causes oxidative stress. To prove this, we modulated the genotoxicity of ANG II with an AT 1 receptor antagonist and with antioxidants. Two standard genotoxicity assays were employed: the micronucleus frequency test, which detects a subset of chromosomal aberrations, inherited to the first generation of daughter cells after mitosis and the comet assay, which detects structural DNA damage, which may partially or completely be transient, then leading to repair before mitosis or to cell death.
METHODS

Materials.
If not mentioned otherwise, all chemicals were purchased from Sigma (Taufkirchen, Germany). Candesartan was provided by AstraZeneca (Wedel, Germany).
Cell culture. LLC-PK 1 cells, an epithelial porcine kidney cell line with proximal tubule properties, were obtained from ATCC and grown as described in Ref. 22 . For experiments, 10 6 cells were treated with test compounds in 5 ml culture medium. The cells were harvested after 24-h incubation with tested compounds for the comet assay and after 48 h for the micronucleus frequency test.
HL-60 cells (human promyelocytic cells) were kindly donated by Prof. R. Schinzel (Vasopharm, Würzburg, Germany). They were grown in RPMI medium, supplemented with 10% fetal calf serum, 1% glutamine, and antibiotics. NRK cells, an epithelial rat kidney cell line with proximal tubule properties, were obtained from ECACC and grown in DMEM medium (4,500 mg glucose/l), supplemented with 10% fetal calf serum, 1% glutamine, 1% nonessential amino acids and antibiotics.
All cells were routinely split twice a week to keep the exponential growth conditions and except for HL-60 (40 passages) were cultured for no more than 20 passages after thawing them from stock.
Comet assay. The comet assay was carried out according to Singh et al. (23) , with slight modifications, as described earlier (22) . A fluorescence microscope at 200-fold magnification and a computeraided image analysis system (Komet 5, Kinetic Imaging LTD, Liverpool, UK) were used for analysis. Fifty cells in total (25 per slide) were analyzed, and results were expressed as percentage of DNA in the tail region.
Micronucleus frequency test. Cells were incubated for 48 h with the tested compounds, and after 24 h 5 g/ml cytochalasin B was added to obtain binucleated cells (BN). For the analysis of the effect of ␣-tocopherol on ANG II-induced micronuclei, the cells were incubated for 24 h simultaneously with test compounds and cytochalasin B. After this incubation, the cells were brought onto glass slides by cytospin centrifugation and fixed with methanol (Ϫ20°C, 1 h). For staining, the slides were incubated with acridine orange (62.5 g/ml in Sørensen buffer, pH 6.8) for 5 min, washed twice with Sørensen buffer for 5 min, and mounted for microscopy. The frequency of micronuclei was obtained after scoring 1,000 BN cells on each of two slides. The averages of three independent experiments are shown.
Quantification of apoptotic cells. During the analysis of the slides prepared for the micronucleus frequency test, cells with nuclei that showed characteristics of apoptotic nuclei (highly condensed chromatin) were also counted and their number was referred to 1,000 BN cells.
Proliferation index. Furthermore, the slides prepared for the micronucleus frequency test were used to calculate the proliferation index of the cells treated with ANG II, using the following formula PI ϭ ͑mononucleated cells * 1͒ ϩ ͑binucleated cells * 2͒
The result is the proliferation index (PI).
RT-PCR experiments.
The expression of mRNA was detected using RT-PCR. Total RNA was isolated from LLC-PK 1 cells with the RNeasy mini kit (Qiagen, Hilden, Germany), and 2.5 g of RNA was used for cDNA synthesis using RevertAid First-Strand cDNA Synthesis Kit (Fermentas GmbH, St. Leon-Rot, Germany). Table 1 shows the primers and conditions used during amplification. All primers were designed with the programme Primer3 (21) .
PCR products were resolved on a 1.5% agarose gel, stained with ethidium bromide. For quantification of the mRNA, the density of the bands was measured using the Gel Doc 2000 (Bio-Rad, Hercules, CA).
PCR products destined for sequencing were cut out of the gel, eluated with the MinElute Gel Extraction Kit (Qiagen), and ligated into the pGEM-T-easy vector (Promega, Madison, WI) and transformed into DH5␣ cells (Invitrogen, Carlsbad, CA). After overnight culture, the plasmids were isolated using the HighSpeed Plasmid Midi Kit (Qiagen) and were sent to MWG-Biotech (Ebersberg, Germany) for sequencing.
Flow cytometric analysis of oxidative stress. 2Ј,7Ј-Dichlorodihydrofluorescein diacetate (H 2DCF-DA) was used to detect ROS production in cells. LLC-PK1 cells were preincubated with 10 M H2DCF-DA for 5 min at 37°C and then ANG II alone, or together with N-acetylcysteine (NAC) or candesartan, was added for an additional 4 h. As a positive control 0.5 M hydrogen peroxide was used after an incubation time of 30 min. For the analysis of the potential antioxidative capacity of candesartan, after the preincubation with H 2DCF-DA, 1.25 M hydrogen peroxide, which yields a similar amount of ROS as 170 nM ANG II, alone, or together with NAC, ␣-tocopherol, or candesartan, was added for an additional 30 min. Cells were harvested, washed three times with PBS/1% BSA, and analyzed (3 ϫ 10 5 cells/sample) by flow cytometry using a FACS LSR I (Becton- The values are means of 3 independent experiments. n. s., Not statistically significant. The number of micronuclei (MN) per 1,000 binucleated cells (BN) in untreated cells and in cells treated with 170 nM as well as the magnitude of micronuclei-induction are shown. The respective cell line was treated in the optimal way to form micronuclei with ANG II: 24-h incubation for HL-60, 48-h incubation for LLC-PK1, and 2-h incubation for NRK. 
RESULTS
The presence of the expression of the AT 1 and the AT 2 receptor in LLC-PK 1 cells was verified by RT-PCR. The obtained sequences were compared with the database GenBank, yielding 99% identity of the LLC-PK 1 AT 1 receptor to the database sequence of Sus sp. mRNA for AT 1 receptor (accession number D11340) and 100% identity of the LLC-PK 1 AT 2 receptor to the database sequence of Sus sp. mRNA for AT 2 receptor (accession number AF195509).
ANG II, in our experiments with LLC-PK 1 , did not change cell proliferation (Table 2) . Also, ANG II did not induce apoptosis, since the number of apoptotic cells observed under the microscope did not rise when increasing doses of ANG II were applied (Table 2) . Of the two other cell lines HL-60 (human promyelocytic cells) and NRK (rat proximal tubule cells) also tested for apoptosis and proliferation after incuba- tion with ANG II, only the NRK cells showed an induction of both apoptosis and proliferation (Table 2) .
ANG II-induced DNA damage was first measured in LLC-PK 1 cells with the comet assay (Fig. 1 ). Upon treatment with ANG II, a dose-dependent increase in genomic damage was demonstrated (Fig. 1B) . A statistically significant genomic damage appeared at 85 nM ANG II and increased with higher doses.
To analyze the role of the AT 1 receptor in ANG II-induced comet formation, the AT 1 receptor antagonist candesartan was added simultaneously with ANG II to the cells (Fig. 2) . Candesartan prevented the ANG II-induced genomic damage completely.
ANG II is known to induce oxidative stress via its AT 1 receptor, which can lead to genomic damage. To demonstrate the participation of oxidative stress in ANG II-induced comet formation, the cells were coincubated with ANG II and the antioxidant NAC. NAC, like candesartan, prevented the ANG II-induced genomic damage (Fig. 2) . Incubation with NAC or candesartan alone did not lead to the formation of comets (data included in the figure legends).
As a second method to measure DNA damage, we chose the micronucleus frequency test. ANG II caused the induction of micronuclei in LLC-PK 1 cells (Fig. 3) , which could also be reduced by NAC and candesartan. The number of micronuclei in cells treated with 170 nM ANG II combined with NAC and candesartan and in cells treated with 340 nM ANG II combined with candesartan did not differ from the control cells. NAC was not able to prevent the induction of micronuclei caused by 340 nM ANG II completely; however, it did reduce them significantly.
Since it was reported that NAC inhibits the binding of ANG II to AT 1 receptor due to its ability to reduce disulfide bonds (28) , the effect of a second antioxidant, which contains no free sulfhydryl groups, ␣-tocopherol, on ANG II-induced DNA damage was examined. As can be seen in Fig. 4A , comet formation due to ANG II incubation was prevented completely. Also, the formation of micronuclei by 170 nM ANG II was inhibited (Fig. 4B) .
The application of the AT 2 receptor antagonist PD123319 to ANG II-treated LLC-PK 1 cells showed that this substance had no effect on the ANG II-induced comet formation (Fig. 5A) . PD123319 lessened the ANG II-caused micronuclei number slightly but was not able to reduce them significantly (Fig. 5B) .
The induction of micronuclei by ANG II was confirmed in two other cell lines, HL-60 and NRK, which also showed an increase in micronuclei-containing cells (Table 2 ). All cell lines (HL-60, LLC-PK 1 , and NRK) had a similar factor of micronuclei induction around 4 ( Table 2 ).
Since we assume that the ANG II-induced genomic damage is caused by the formation of ROS upon AT 1 -mediated activation of the NAD(P)H oxidase, the generation of ROS was measured flow cytometrically. As shown in Fig. 6 , ANG II led to a significant formation of ROS, which could be prevented either by candesartan, NAC, or ␣-tocopherol.
To exclude the possibility of candesartan being a radical scavenger itself, a coincubation of LLC-PK 1 cells with hydrogen peroxide (H 2 O 2 ) and candesartan was performed (Fig. 7 , 
A-D)
. An H 2 O 2 concentration was chosen, which led to a shift to the right of the curve, comparable to the shift caused by 170 nM ANG II (see Fig. 6 ), and which also caused DNA damage in the comet assay (Fig. 7E) . The flow cytometric analysis of this experiment showed that candesartan could not reduce the H 2 O 2 -induced oxidative stress in the cells, in contrast to NAC, which could.
DISCUSSION
In LLC-PK 1 pig kidney cells, we detected a direct DNA damaging potential of ANG II by the comet assay. Thus our data confirm and extend similar observations in cells of the ascending limb of the loop of Henle (20) and in microvessel endothelial cells (18) . For the first time, chromosomal mutations caused by ANG II as revealed by micronucleus formation were observed. Micronuclei were induced in three different cell lines, in LLC-PK 1 , in rat kidney cells (NRK), and in human promyelocytic cells (HL-60).
Depending on the cell type, the stimulation of the ANG II receptor AT 1 leads to cellular contraction, hypertrophy, proliferation, and/or apoptosis (31) . In LLC-PK 1 , ANG II had no impact on the proliferation or the apoptosis rate in contrast to observations by Hannken et al. (10) , who detected a cell cycle arrest in LLC-PK 1 . This difference might be due to the pres- ence of serum in our experiments, while Hannken et al. incubated serum free. Of the other two cell lines we analyzed for micronuclei induction with ANG II, only the rat kidney cells showed enhanced proliferation and apoptosis.
Coincubation with the AT 1 receptor antagonist candesartan prevented the appearance of genomic damage detected with the comet assay and the micronucleus frequency test, while the application of the AT 2 receptor antagonist PD123319 had no effect.
It is well-known that ANG II binding to the AT 1 receptor induces NAD(P)H oxidases, resulting in the generation of superoxide anions (7) . This was also already demonstrated for LLC-PK 1 cells (10). Here, it is shown for the first time that the genotoxic action of ANG II in the comet assay and its micronuclei-inducing effect could be prevented by the antioxidants NAC and ␣-tocopherol, linking the formation of ROS to the genotoxic effects.
DNA damage caused by ROS involves single-or doublestrand DNA breaks, purine, pyrimidine, or deoxyribose modifications, and DNA cross-links (29) . DNA repair, which starts after the oxidative attack on the chromosomes, often transforms the above-mentioned modifications to additional strand breaks. The comet assay detects such structural DNA damage (1), which, as we have shown, was also induced by incubation with ANG II. Micronuclei are formed for example after double-strand breaks which lead to chromosome fragments lagging behind at the anaphase during nuclear division (5) . Hydrogen peroxide induces DNA double-strand breaks in a time-and dose-dependent manner, as revealed by an antibody specifically detecting double-strand breaks (15) . Superoxide anions released after ANG II stimulation by NAD(P)H oxidase are rapidly converted to hydrogen peroxide (8) , which can lead to the ANG II-induced micronuclei.
Our evidence for ANG II-induced genomic damage in renal tubular cells could be of significance with regard to the increased occurrence of kidney carcinomas under an activated renin-angiotensin-system (6, 19) . In animal models, it was shown that the concentration of ANG II in the kidney is 25 to 1,000 times higher than in plasma (24, 30) . Under pathological conditions, the ANG II concentration in the renal interstitial fluid of dogs can reach 800 nM (24) implying a physiological relevance of a genotoxic effect of 85 nM ANG II.
In the presence of hypertension, the incidence of renal cancer is enhanced (3). The potential involvement of a stimulated RAS in the kidney is underlined by the observation that long-term treatment with diuretics is associated with an increased risk of renal cancer (9) . On the contrary, ANG I-converting enzyme inhibitors have been discussed as anticancer drugs (16) , and ANG II type 1 receptor blockers have been tested in a pilot study with patients who suffer from advanced hormone-refractory prostate cancer (26, 27) .
In conclusion, our in vitro results show that ANG II induces genomic damage in mammalian cells, most likely via oxidative mechanisms. This injury can be prevented by ANG II type 1 receptor blockade and by antioxidants.
